Byrnes Michael

CIK 00016198933 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001619893

Recent Transactions

35 trades

Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2026-01-07+690,900→ 690,900 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-05-30+9,326→ 9,326 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-03-04+17,923→ 17,923 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2025-02-24+127,500→ 255,000 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-12-02+127,500→ 127,500 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2024-05-15$1.68/sh+1,387→ 3,117 total
Award
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Stock Option (Right to Buy)
2024-03-25+112,500→ 112,500 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2024-02-19+40,000→ 40,000 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2023-11-15$0.50/sh+4,524→ 43,271 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2023-05-15$0.46/sh+4,863→ 38,747 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2023-01-17+500,000→ 500,000 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2022-11-15$0.47/sh+4,651→ 33,884 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-20+235,541→ 235,541 total
Purchase
eFFECTOR Therapeutics, Inc.
Common Stock
2022-06-07$1.33/sh+25,000→ 29,233 total
Award
eFFECTOR Therapeutics, Inc.
Common Stock
2022-05-13$1.53/sh+4,233→ 4,233 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2022-01-20+235,541→ 235,541 total
Award
eFFECTOR Therapeutics, Inc.
Earn-out Right
2021-08-25+49,790→ 49,790 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2021-08-25+337,997→ 337,997 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2017-12-11−70,000→ 0 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2017-12-11−123,300→ 0 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2017-12-11−75,000→ 0 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2017-12-11−55,000→ 0 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Common Stock
2017-12-11$1.52/sh−150,000→ 0 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2017-12-11−102,300→ 0 total
Disposition to Issuer
Ocera Therapeutics, Inc.
Common Stock
2017-12-11$1.52/sh−13,000→ 0 total
Award
Ocera Therapeutics, Inc.
Common Stock
2017-03-29+150,000→ 163,000 total
Purchase
Ocera Therapeutics, Inc.
Common Stock
2017-03-28$1.28/sh+3,000→ 13,000 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2016-12-15+102,300→ 102,300 total
Purchase
Ocera Therapeutics, Inc.
Common Stock
2016-01-15$2.07/sh+3,500→ 10,000 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2016-01-06+41,100→ 41,100 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2016-01-06+123,300→ 123,300 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2015-06-18+75,000→ 75,000 total
Purchase
Ocera Therapeutics, Inc.
Common Stock
2015-05-06$3.61/sh+2,500→ 6,500 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2014-12-02+70,000→ 70,000 total
Purchase
Ocera Therapeutics, Inc.
Common Stock
2014-10-01$4.81/sh+2,000→ 4,000 total

Byrnes Michael

Recent Transactions

Companies

Recent Filings

Address